1st mpox vaccine for children approved by WHO – National Aitrend

1st mpox vaccine for children approved by WHO – National

 Aitrend

The World Health Organization authorized the first MPOX vaccine for children, a move that experts hope will help make vaccines more widely available to one of the hardest-hit populations during ongoing outbreaks of the disease in Congo and elsewhere in Africa. In a statement Tuesday evening, the United Nations health agency said it had approved … Read more

Vaccine trial results in 88% survival rate after 3 years Aitrend

Vaccine trial results in 88% survival rate after 3 years

 Aitrend

Study author, William Gillanders – credit, SWNS Breast cancer patients have found new hope after a new vaccine showed “promise” in treating an aggressive form of the disease. The findings come from a clinical trial involving U.S. patients with triple-negative breast cancer who received an experimental drug designed to prevent tumors from recurring. The trial, … Read more